Search
SOLACI Congress
HomeFile

File

View Category
Chronic Coronary Syndromes

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an...
Dr. Omar Tupayachi -
Learn More
Acute coronary syndromes

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to...
Dr. Andrés Rodríguez -
Learn More
Acute coronary syndromes

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as...
Dr. Andrés Rodríguez -
Learn More
Chronic Coronary Syndromes

iVAC2L: New Contribution to Ventricular Assist Devices in High Risk PCIs

The use of mechanical circulatory support (MCS) is on the rise, or increasingly necessary, seeing as high...
Dr. Carlos Fava -
Learn More
Calcified Lesions

Post IVL Coronary Compliance

Calcified coronary lesions represent one of the most relevant technical challenges in percutaneous coronary intervention (PCI). Its...
Dr. Carlos Fava -
Learn More
Bifurcations

Side Branch Treatment in Bifurcation Lesions: Are Drug-Coated Balloons Better?

Courtesy of Dr. Juan Manuel Pérez. Bifurcation lesions account for up to 20% of all coronary angioplasties. The...
Dr. Juan Manuel Pérez -
Learn More
Chronic Coronary Syndromes

Ischemia by Dobutamine Stress Echocardiography as a Predictor of PCI Efficacy

Patients with coronary artery disease (CAD) or chronic coronary syndromes (CCS) present a challenge in selecting the...
Dr. Omar Tupayachi -
Learn More
Chronic Ischemic cardiopathy

IVUS Assessment in Patients at High Risk of Coronary Occlusion After TAVI: Results from the ICARO Study

Courtesy of Dr. Juan Manuel Pérez. Acute coronary obstruction (ACO) is a rare but potentially fatal complication following...
Dr. Juan Manuel Pérez -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy